According to the latest data from the Hong Kong Stock Exchange, on January 13, HFT Investment Management Co., Ltd. increased its stake in 3SBIO (01530) by 1.4925 million shares. The transaction was executed at a price of HK$28.1794 per share, amounting to a total consideration of approximately HK$42.06 million. Following this acquisition, HFT Investment Management's total shareholding has risen to approximately 153 million shares, representing a 6.02% stake in the company.